231 results on '"Helldin, Lars"'
Search Results
2. Exploring cross-sectional and longitudinal symptomatic remission and subjective quality of life in schizophrenia
3. Neurocognitive function and mortality in patients with schizophrenia spectrum disorders
4. Cognitive markers related to long-term remission status in Schizophrenia Spectrum Disorders
5. Neurocognitive variability in schizophrenia spectrum disorders: relationship to real-world functioning
6. Overestimated function in patients with schizophrenia: A possible risk factor for inadequate support?
7. Correlates of risk factors for reduced life expectancy in schizophrenia: Is it possible to develop a predictor profile?
8. Positive and negative affect in schizophrenia spectrum disorders: A forgotten dimension?
9. What could be learned from a decade with standardized remission criteria in schizophrenia spectrum disorders: An exploratory follow-up study
10. Insight, satisfaction with pharmacological treatment and treatment outcome in patients with schizophrenia: results of the long-term prospective study CLIPS
11. Predicting real-world functional milestones in schizophrenia
12. Cognitive performance, symptom severity, and survival among patients with schizophrenia spectrum disorder: A prospective 15-year study
13. Assessment of Distress and Quality of Life: A Comparison of Self-Assessments by Outpatients with a Schizopsychotic Illness and the Clinical Judgment of Nurses
14. Culture as a predictor of resistance to change: A study of competing values in a psychiatric nursing context
15. Psychometric properties of a performance-based measurement of functional capacity, the UCSD Performance-based Skills Assessment - Brief version
16. The importance of cross-sectional remission in schizophrenia for long-term outcome: A clinical prospective study
17. Family burden and functional assessment in the Swedish CLIPS-study: do staff and relatives agree on individuals with psychotic disorders’ functional status?
18. Illness-related components for the family burden of relatives to patients with psychotic illness
19. Psychometric properties of the burden inventory for relatives of persons with psychotic disturbances
20. Marginal relationship between affective dispositions and neurocognitive function in patients with schizophrenia spectrum disorders
21. Remission in schizophrenia: Applying recent consensus criteria to refine the concept
22. Remission in prognosis of functional outcome: A new dimension in the treatment of patients with psychotic disorders
23. Verbal learning in schizopsychotic outpatients and healthy volunteers as a function of cognitive performance levels
24. Measuring adult Attention Deficit Hyperactivity Disorder using the Quantified Behavior Test Plus
25. Remission and cognitive ability in a cohort of patients with schizophrenia
26. Validating the remission concept: can we make it clinically meaningful to the patients and psychiatrists?
27. Marginal relationship between affective dispositions and neurocognitive function in patients with schizophrenia spectrum disorders
28. S48. INSIGHT VS COGNITION AND SYMPTOMATIC REMISSION AMONG PATIENTS WITH SCHIZOPHRENIA- THE INFLUENCE OF TRAIT VS STATE PHENOMENON?
29. M219. OVERESTIMATING FUNCTION – A RISK FACTOR FOR SUBOPTIMAL COMMUNITY AID IN SCHIZOPHRENIA
30. M86. CAN WEIGHT GAIN CAUSE METABOLIC SYNDROME A DECADE LATER IN PATIENTS WITH SCHIZOPHRENIA SPECTRUM DISORDER?
31. Performance-Based Measurement of Functional Disability in Schizophrenia: A Cross-National Study in the United States and Sweden
32. Insight vs cognition and symptomatic remission among patients with schizophrenia : The influence of trait vs state phenomenon?
33. F123. ASSESSING EVERYDAY FUNCTIONING IN PATIENTS WITH SCHIZOPHRENIA: THE IMPORTANCE OF INTROSPECTIVE ACCURACY
34. F122. OVERESTIMATING FUNCTIONING AND LONG-TERM SYMPTOMATIC REMISSION PATTERN – HOW IS IT ASSOCIATED?
35. The Impact of Repeated Assessments by Patients and Professionals : A 4-Year Follow-Up of a Population With Schizophrenia
36. Overestimating Functioning and Long-term Symptomatic Remission Pattern - How Is It Associated?
37. Less symptoms in schizophrenia a risk factor for impaired insight of functioning?
38. Factors That Promote Remission in Individuals with Schizophrenia
39. The Impact of Repeated Assessments by Patients and Professionals: A 4-Year Follow-Up of a Population With Schizophrenia
40. T112. TRADITIONAL RISK FACTORS NOT ENOUGH TO EXPLAIN THE SHORT LIFETIME EXPECTANCY IN PATIENTS WITH SCHIZOPHRENIA
41. F112. LESS SYMPTOMS IN SCHIZOPHRENIA – A RISK FACTOR FOR IMPAIRED INSIGHT OF FUNCTIONING?
42. F116. CAN INSIGHT LEAD TO REMISSION - FOR PATIENTS WITH SCHIZOPHRENIA?
43. Can Insight Lead To Remission - For Patients With Schizophrenia?
44. Traditional Risk Factors Not Enough To Explain The Short Lifetime Expectancy In Patients With Schizophrenia
45. SU42. Physical Fitness in Association With Cognitive Performance—Possible Marker of Short Lifetime Expectancy for Patients With Schizophrenia
46. SU31. Cognition in Schizophrenia a Comparison With Healthy Controls—Cognitive Ability and Its Influence on Functional Outcome
47. SU42. Physical Fitness in Association With Cognitive Performance—Possible Marker of Short Lifetime Expectancy for Patients With Schizophrenia
48. Schizophrenia and Short Lifetime Expectancy : The Importance of Identifying Risk Factors Early in the Illness.
49. Why Don’t You Give Me a Call? : The Impact of Memory Deficits on Everyday Activities.
50. Average life-time among schizophrenia patients is closer linked to cognitive ability than to symptom activity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.